Cencora Inc. (COR)
NYSE · Healthcare · Medical Distribution
Cencora Inc. is a Healthcare company with a market capitalization of $58.34B, a trailing P/E ratio of 22.7, and a dividend yield of 0.76%.
5-Year Price History
Latest Annual Financials · FY ending September 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | May 6, 2026 | $4.75 | $4.73 | +0.4% |
| Q1 2026 | February 4, 2026 | $4.08 | $4.04 | +1.0% |
| Q4 2025 | November 5, 2025 | $3.84 | $3.79 | +1.3% |
| Q3 2025 | August 6, 2025 | $4.00 | $3.84 | +4.2% |
| Q2 2025 | May 7, 2025 | $4.42 | $4.10 | +7.8% |
| Q1 2025 | February 5, 2025 | $3.73 | $3.52 | +6.0% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 5,872,438 | 3.01% | 3.9 | +6.8% |
| June 30, 2026 | 5,498,838 | 2.81% | 3.0 | -11.8% |
| June 15, 2026 | 6,237,168 | 3.19% | 4.7 | +12.9% |
| May 29, 2026 | 5,526,396 | 2.83% | 3.0 | +4.5% |
| May 15, 2026 | 5,289,439 | 2.71% | 1.8 | +1.9% |
| April 30, 2026 | 5,191,933 | 2.66% | 3.5 | +7.3% |
| April 15, 2026 | 4,841,063 | 2.48% | 4.1 | -6.1% |
| March 31, 2026 | 5,155,259 | 2.64% | 2.7 | +4.9% |
Other Medical Distribution Stocks
Frequently Asked Questions
What is Cencora Inc.'s market cap?
As of August 13, 2026, Cencora Inc. (COR) has a market capitalization of $58.34B.
What is Cencora Inc.'s P/E ratio?
Cencora Inc. trades at a trailing price-to-earnings (P/E) ratio of 22.7. Its forward P/E is 15.3.
Does Cencora Inc. pay a dividend?
Yes — Cencora Inc. pays a dividend yielding 0.76%, an annual payout of $2.35 per share.
What sector is COR in?
Cencora Inc. is in the Healthcare sector, specifically the Medical Distribution industry.
What is Cencora Inc.'s short interest?
As of the July 15, 2026 FINRA settlement, 5,872,438 COR shares were sold short, or 3.01% of shares outstanding. Days to cover: 3.9. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Cencora Inc.'s revenue?
In its latest reported fiscal year (ending September 30, 2025), Cencora Inc. reported revenue of $321.33B and net income of $1.55B.
Ask your own questions about COR
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.